Peter M.J. Quinn is a British molecular geneticist, stem cell biologist, and genome engineer. Dr. Quinn is an Assistant Professor of Ophthalmology and Principal Investigator of the PrimeSight Lab at the University of Pennsylvania. The labs focus is to provide clinically translatable impact using iPSC-derived ophthalmic organoid-based approaches for the understanding and treatment of retinal degenerative diseases. The PrimeSight team is currently developing gene-specific and gene-agnostic therapeutics for the amelioration of the phenotypic, histopathological, and molecular changes in several inherited retinal disease iPSC-derived retinal organoid models. Further, they are establishing projects on autosomal dominant optic atrophy and genetic glaucoma. Please donate to our research: https://giving.apps.upenn.edu/fund?program=MED&fund=605907